CDR1as can sponge miR-641 to enhance the expression of HOXA9, thereby stimulating stemness and cisplatin chemoresistance in non-small-cell lung cancer (NSCLC).131. This evidence concerns the gene HOXA9 and non-small cell lung carcinoma.